The Surgical Company International BV (As the 37company)
FDA decision date
May 26, 2017
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Decision stated in the source
Substantially Equivalent
Source facts
Decision
Substantially Equivalent
Received
2017-04-27
Specialty
Cardiovascular
Decision code
SESE
Clearance type
Special
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.